![Cellphone with logo of US biotechnology company Sage Therapeutics Inc. on screen in front of website. Focus on center-right of phone display Stock Photo - Alamy Cellphone with logo of US biotechnology company Sage Therapeutics Inc. on screen in front of website. Focus on center-right of phone display Stock Photo - Alamy](https://c8.alamy.com/comp/2GG8RN8/cellphone-with-logo-of-us-biotechnology-company-sage-therapeutics-inc-on-screen-in-front-of-website-focus-on-center-right-of-phone-display-2GG8RN8.jpg)
Cellphone with logo of US biotechnology company Sage Therapeutics Inc. on screen in front of website. Focus on center-right of phone display Stock Photo - Alamy
![Sage Therapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation (NASDAQ:SAGE) | Seeking Alpha Sage Therapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation (NASDAQ:SAGE) | Seeking Alpha](https://static.seekingalpha.com/uploads/sa_presentations/921/75921/slides/1.jpg?1635880187)
Sage Therapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation (NASDAQ:SAGE) | Seeking Alpha
![Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea | Business Wire Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea | Business Wire](https://mms.businesswire.com/media/20180613006173/en/522140/5/Sage_Logo_CMYK.jpg)